Related Experiment Video
Updated: Feb 13, 2026

Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
Published on: September 28, 2022
A genetically selected cyclic peptide inhibitor of BCL6 homodimerization
Eliot L Osher1, Francisco Castillo1, Nagarajan Elumalai1
1Chemistry, University of Southampton, Southampton SO17 1BJ, UK.
Abstract:
We report an inhibitor of the homodimeric protein-protein interaction of the BCL6 oncoprotein, identified from a genetically encoded SICLOPPS library of 3.2 million cyclic hexapeptides in combination with a bacterial reverse two-hybrid system. This cyclic peptide is shown to bind the BTB domain of BCL6, disrupts its homodimerization, and subsequent binding of the SMRT2 corepressor peptide.
Related Concept Videos
Peptide Bonds
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
What is Natural Selection?
Stereoisomerism of Cyclic Compounds
Genetics of Speciation
What is Population Genetics?

